Cancer as a Risk Factor for Cardiovascular Disease

被引:0
作者
Dana Elena Giza
Gloria Iliescu
Saamir Hassan
Konstantinos Marmagkiolis
Cezar Iliescu
机构
[1] The University of Texas MD Anderson Cancer Center,Department of Cardiology
[2] The University of Texas MD Anderson Cancer Center,Department of General Internal Medicine, Division of Internal Medicine
[3] Citizens Memorial Hospital,Heart and Vascular Institute
[4] University of Missouri,undefined
来源
Current Oncology Reports | 2017年 / 19卷
关键词
Cardiovascular disease; Risk factors; Cancer; Cardiotoxicity; Radiation; Atherosclerosis; Anthracyclines; Cardiac biomarkers; LVEF;
D O I
暂无
中图分类号
学科分类号
摘要
Improvements in early diagnosis and cancer treatments have contributed to high survival rates for many cancer patients. However, these patients often die of cardiovascular disease rather than recurrence of their cancer. Heart disease manifesting after cancer may be due to several mechanisms: shared cardiovascular risks between cancer and cardiovascular disease, inflammatory states associated with malignancies, and/or cardiotoxic effects of cancer therapy. Cancer treatment increases the risk of cardiovascular diseases directly by damaging critical structures of the heart or indirectly by promoting accelerated atherosclerosis. Estimating cardiovascular risk by using advanced imaging and monitoring of the cardiac biomarkers can be used for early detection and treatment of subclinical cardiac injury. Better knowledge of these early and late cardiac effects in cancer patients will enable adoption of both primary and secondary prevention measures of long-term treatment complications in cancer survivors.
引用
收藏
相关论文
共 224 条
[1]  
Siegel R(2012)Cancer treatment and survivorship statistics, 2012 CA Cancer J Clin 62 220-241
[2]  
DeSantis C(2013)Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? J Cancer Surviv 7 253-261
[3]  
Virgo K(2015)Cancer statistics, 2015 CA Cancer J Clin 65 5-29
[4]  
Weaver KE(2014)Cardiovascular disease after cancer therapy EJC supplements : EJC: official journal of EORTC, European Organization for Research and Treatment of Cancer … [et al] 12 18-28
[5]  
Foraker RE(2016)Shared risk factors for cardiovascular disease and cancer: implications for preventive health and clinical care in oncology patients Can J Cardiol 32 900-907
[6]  
Alfano CM(2002)Inflammation in atherosclerosis Nature 420 868-874
[7]  
Siegel RL(2004)Role of endothelial dysfunction in atherosclerosis Circulation 109 III27-III32
[8]  
Miller KD(2011)Early detection and prediction of cardiotoxicity in chemotherapy-treated patients Am J Cardiol 107 1375-1380
[9]  
Jemal A(2012)Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis Proc Natl Acad Sci U S A 109 13076-13081
[10]  
Aleman BM(2011)Arterial and venous thrombosis in cancer patients Cardiol Res Pract 2011 394740-530